{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T12:36:14Z","timestamp":1791030974629,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd005011.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2012,3,14]],"date-time":"2012-03-14T00:00:00Z","timestamp":1331683200000}}],"reference-count":105,"publisher":"Wiley","issue":"4","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd005011.pub4","type":"journal-article","created":{"date-parts":[[2012,3,9]],"date-time":"2012-03-09T15:44:14Z","timestamp":1331307854000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":96,"title":["Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia"],"prefix":"10.1002","volume":"2012","author":[{"given":"Ewurabena","family":"Simpson","sequence":"first","affiliation":[{"name":"The Hospital for Sick Children; Department of Paediatrics, Division of Haematology\/Oncology; 555 University Avenue Toronto ON Canada M5G 1X8"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulia","family":"Lin","sequence":"additional","affiliation":[{"name":"Sunnybrook Health Sciences Centre and Canadian Blood Services; Department of Clinical Pathology; 2075 Bayview Avenue, Room B204 Toronto Ontario Canada M4N 3M5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Stanworth","sequence":"additional","affiliation":[{"name":"NHS Blood and Transplant; Haematology\/Transfusion Medicine; Level 2, John Radcliffe Hospital Headington Oxford UK OX3 9BQ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Birchall","sequence":"additional","affiliation":[{"name":"NHS Blood and Transplant, Bristol and North Bristol NHS Trust; Haematology\/Transfusion Medicine; Bristol UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Doree","sequence":"additional","affiliation":[{"name":"NHS Blood and Transplant; Systematic Review Initiative; John Radcliffe Hospital Oxford UK OX3 9BQ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Hyde","sequence":"additional","affiliation":[{"name":"Peninsula College of Medicine & Dentistry; Peninsula Technology Assessment Group (PenTAG); Veysey Building Salmon Pool Lane Exeter UK EX2 4SG"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,3,14]]},"reference":[{"issue":"1","key":"10.1002\/14651858.CD005011.pub4-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/01.TA.0000171453.37949.B7","article-title":"Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized placebo-controlled double blind clinical trials","volume":"59","author":"Boffard","year":"2005","journal-title":"Journal of Trauma"},{"issue":"1","key":"10.1002\/14651858.CD005011.pub4-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/01.TA.0000171453.37949.B7","article-title":"Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized placebo-controlled double blind clinical trials","volume":"59","author":"Boffard","year":"2005","journal-title":"Journal of Trauma"},{"issue":"4","key":"10.1002\/14651858.CD005011.pub4-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1053\/j.gastro.2004.07.015","article-title":"Recombinant factor VIIa for upper gastrointestinal bleeding patients with cirrhosis: a randomized, double-blind trial","volume":"127","author":"Bosch","year":"2004","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD005011.pub4-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1002\/hep.22216","article-title":"Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: a randomized, controlled trial","volume":"47","author":"Bosch","year":"2008","journal-title":"Hepatology"},{"issue":"8","key":"10.1002\/14651858.CD005011.pub4-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/01.mbc.0000186837.78432.2f","article-title":"Control of bleeding in children with Dengue hemorrhagic fever using recombinant activated factor VII: a randomized, double-blind, placebo-controlled study","volume":"16","author":"Chuansumrit","year":"2005","journal-title":"Blood Coagulation & Fibrinolysis"},{"issue":"Suppl 33","key":"10.1002\/14651858.CD005011.pub4-BIB0006|cit6","first-page":"2","article-title":"A pilot double blind randomized placebo-controlled trial of the use of recombinant factor VIIa (rf VIIa) in high transfusion risk cardiac surgery","volume":"21","author":"Diprose","year":"2005","journal-title":"European Journal of Anaesthesiology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD005011.pub4-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1097\/00001721-200405001-00007","article-title":"Recombinant activated factor VII in cardiac surgery","volume":"15","author":"Herbertson","year":"2004","journal-title":"Blood Coagulation & Fibrinolysis"},{"issue":"5","key":"10.1002\/14651858.CD005011.pub4-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/01.mbc.0000233369.03358.c1","article-title":"Elective administration in infants of low-dose recombinant activated factor VII (rFVIIa) in cardiopulmonary bypass surgery for congenital heart disease does not shorten time to chest closure or reduce blood loss and need for transfusions: a randomized, double-blind, parallel group, placebo-controlled study of rFVIIa and standard haemostatic replacement therapy versus standard haemostatic replacement therapy","volume":"17","author":"Ekert","year":"2006","journal-title":"Blood Coagulation & Fibrinolysis"},{"issue":"1","key":"10.1002\/14651858.CD005011.pub4-BIB0009|cit9","first-page":"10","article-title":"Prophylactic administration of recombinant activated factor VII in coronary revascularization surgery","volume":"13","author":"Essam","year":"2007","journal-title":"Internet Journal of Anesthesiology"},{"issue":"2","key":"10.1002\/14651858.CD005011.pub4-BIB0010|cit10","first-page":"112","article-title":"Novel applications of recombinant factor VIIa: the effect of the administration of recombinant activated factor VII on perioperative blood loss in patients undergoing transabdominal retropubic prostatectomy: the PROSE study","volume":"28","author":"Friederich","year":"2001","journal-title":"Infusionstherapie und Transfusionsmedizin"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD005011.pub4-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1097\/00001721-200004001-00024","article-title":"The effect of the administration of recombinant activated factor VII on perioperative blood loss in patients undergoing transabdominal retropubic prostatectomy: the PROSE study","volume":"11","author":"Friederich","year":"2000","journal-title":"Blood Coagulation & Fibrinolysis"},{"issue":"9353","key":"10.1002\/14651858.CD005011.pub4-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0140-6736(03)12268-4","article-title":"Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomised trial","volume":"361","author":"Friederich","year":"2003","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD005011.pub4-BIB0013|cit13","unstructured":"Gill R Herbertson M Vuylsteke A Olsen P S von Heymann C Mythen M Additional data obtained from author 2009"},{"issue":"1","key":"10.1002\/14651858.CD005011.pub4-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1161\/CIRCULATIONAHA.108.834275","article-title":"Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery","volume":"120","author":"Gill","year":"2009","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD005011.pub4-BIB0015|cit15","first-page":"53","article-title":"Reduction of peri-operative bleeding in craniofacial surgeries in pediatrics. Comparison between recombinant factor VII and tranexamic acid","volume":"26","author":"Hanna","year":"2010","journal-title":"Egyptian Journal of Anaesthesia"},{"issue":"3","key":"10.1002\/14651858.CD005011.pub4-BIB0016|cit16","first-page":"489","article-title":"Results of the CONTROL trial: efficacy and safety of recombinant activated factor VII in the management of refractory traumatic hemorrhage","volume":"69","author":"Hauser","year":"2010","journal-title":"Journal of Trauma"},{"issue":"3","key":"10.1002\/14651858.CD005011.pub4-BIB0017|cit17","first-page":"489","article-title":"Results of the CONTROL trial: efficacy and safety of recombinant activated factor VII in the management of refractory traumatic hemorrhage","volume":"69","author":"Hauser","year":"2010","journal-title":"Journal of Trauma"},{"key":"10.1002\/14651858.CD005011.pub4-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1053\/gast.2002.34164","article-title":"Safety and efficacy of recombinant factor VIIa in patients with liver disease undergoing laparoscopic liver biopsy","volume":"123","author":"Jeffers","year":"2002","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD005011.pub4-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.burns.2006.08.010","article-title":"Recombinant FVIIa decreases perioperative blood transfusion requirement in burn patients undergoing excision and skin grafting - results of a single centre pilot study","volume":"33","author":"Johansson","year":"2007","journal-title":"Burns"},{"issue":"2","key":"10.1002\/14651858.CD005011.pub4-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00000542-200502000-00006","article-title":"Recombinant coagulation factor VIIa in major liver resection: a randomized, placebo-controlled, double-blind clinical trial","volume":"102","author":"Lodge","year":"2005","journal-title":"Anesthesiology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD005011.pub4-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1053\/j.seminhematol.2003.11.014","article-title":"Hemostasis in liver resection surgery","volume":"41","author":"Lodge","year":"2004","journal-title":"Seminars in Hematology"},{"issue":"8","key":"10.1002\/14651858.CD005011.pub4-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/lt.20470","article-title":"Efficacy and safety of repeated perioperative doses of recombinant factor VIIa in liver transplantation","volume":"11","author":"Lodge","year":"2005","journal-title":"Liver Transplantation"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD005011.pub4-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1053\/j.seminhematol.2003.11.014","article-title":"Hemostasis in liver resection surgery","volume":"41","author":"Lodge","year":"2004","journal-title":"Seminars in Hematology"},{"key":"10.1002\/14651858.CD005011.pub4-BIB0024|cit24","first-page":"1110","article-title":"Effect of recombinant activated factor VIIa on early recovery of patients undergoing cardiac valve replacement under cardiopulmonary bypass: a randomized double-blind placebo-controlled trial","volume":"27","author":"Ma","year":"2006","journal-title":"Academic Journal of Second Military Medical University"},{"key":"10.1002\/14651858.CD005011.pub4-BIB0026|cit25","doi-asserted-by":"crossref","first-page":"S235","DOI":"10.1007\/s00134-002-1470-8","article-title":"Intracerebral hemorrhage: natural history and rationale of ultra-early hemostatic therapy","volume":"28","author":"Mayer","year":"2002","journal-title":"Intensive Care Medicine"},{"issue":"8","key":"10.1002\/14651858.CD005011.pub4-BIB0025|cit26","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJMoa042991","article-title":"Recombinant activated factor VII for acute intracerebral hemorrhage","volume":"352","author":"Mayer","year":"2005","journal-title":"New England Journal of Medicine"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD005011.pub4-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1097\/00001721-200004001-00022","article-title":"Potential role of NovoSeven in the prevention of rebleeding following aneurysmal subarachnoid haemorrhage","volume":"11","author":"Pickard","year":"2000","journal-title":"Blood Coagulation & Fibrinolysis"},{"key":"10.1002\/14651858.CD005011.pub4-BIB0029|cit28","doi-asserted-by":"crossref","first-page":"S235","DOI":"10.1007\/s00134-002-1470-8","article-title":"Intracerebral hemorrhage: natural history and rationale of ultra-early hemostatic therapy","volume":"28","author":"Mayer","year":"2002","journal-title":"Intensive Care Medicine"},{"issue":"1","key":"10.1002\/14651858.CD005011.pub4-BIB0028|cit29","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1161\/01.STR.0000149628.80251.b8","article-title":"Safety and feasibility of recombinant factor VIIa for acute intracerebral hemorrhage","volume":"36","author":"Mayer","year":"2005","journal-title":"Stroke"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD005011.pub4-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1097\/00001721-200004001-00022","article-title":"Potential role of NovoSeven in the prevention of rebleeding following aneurysmal subarachnoid haemorrhage","volume":"11","author":"Pickard","year":"2000","journal-title":"Blood Coagulation & Fibrinolysis"},{"issue":"3","key":"10.1002\/14651858.CD005011.pub4-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1385\/NCC:4:3:206","article-title":"Recombinant activated factor VII for acute intracerebral hemorrhage: US phase IIA trial","volume":"4","author":"Mayer","year":"2006","journal-title":"Neurocritical Care"},{"issue":"20","key":"10.1002\/14651858.CD005011.pub4-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1056\/NEJMoa0707534","article-title":"Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage","volume":"358","author":"Mayer","year":"2008","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD005011.pub4-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1227\/01.neu.0000316898.78371.74","article-title":"Recombinant factor VIIA in traumatic intracerebral hemorrhage: results of a dose-escalation clinical trial","volume":"62","author":"Narayan","year":"2008","journal-title":"Neurosurgery"},{"key":"10.1002\/14651858.CD005011.pub4-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/S0268-960X(03)90001-4","article-title":"Haemopoietic stem cell transplants: the impact of haemorrhagic complications","volume":"17","author":"Bacigalupo","year":"2003","journal-title":"Blood Reviews"},{"issue":"9","key":"10.1002\/14651858.CD005011.pub4-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1111\/j.1538-7836.2005.01523.x","article-title":"Recombinant activated factor VII in treatment of bleeding complications following hematopoietic stem cell transplantation","volume":"3","author":"Pihusch","year":"2005","journal-title":"Journal of Thrombosis & Haemostasis"},{"issue":"8","key":"10.1002\/14651858.CD005011.pub4-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/lt.20458","article-title":"Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation due to chronic liver disease","volume":"11","author":"Planinsic","year":"2005","journal-title":"Liver Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD005011.pub4-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/j.transproceed.2007.05.062","article-title":"Activated recombinant factor VII in orthotopic liver transplantation","volume":"39","author":"Pugliese","year":"2007","journal-title":"Transplantation Proceedings"},{"issue":"5","key":"10.1002\/14651858.CD005011.pub4-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/bja\/aei102","article-title":"Use of activated recombinant coagulation factor VII in patients undergoing reconstruction surgery for traumatic fracture of pelvis and acetabulum: a double-blind randomized, placebo-controlled trial","volume":"94","author":"Raobaikady","year":"2005","journal-title":"British Journal of Anaesthesia"},{"issue":"21","key":"10.1002\/14651858.CD005011.pub4-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1097\/BRS.0b013e3181557d45","article-title":"Recombinant activated factor VII in spinal surgery: a multicenter, randomized, double-blind, placebo-controlled, dose-escalation trial","volume":"32","author":"Sachs","year":"2007","journal-title":"Spine"},{"issue":"2","key":"10.1002\/14651858.CD005011.pub4-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.amjsurg.2005.10.019","article-title":"Safety and hemostatic effect of recombinant activated factor VIIa in cirrhotic patients undergoing partial hepatectomy: a multicenter, randomized, double-blind, placebo-controlled trial","volume":"191","author":"Shao","year":"2006","journal-title":"American Journal of Surgery"},{"issue":"12","key":"10.1002\/14651858.CD005011.pub4-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/sj.bmt.1705535","article-title":"Pilot study to test the efficacy and safety of activated recombinant factor VII (NovoSeven) in the treatment of refractory hemorrhagic cystitis following high-dose chemotherapy","volume":"38","author":"Ashrani","year":"2006","journal-title":"Bone Marrow Transplantation"},{"issue":"20","key":"10.1002\/14651858.CD005011.pub4-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1161\/01.CIR.0000038501.87442.02","article-title":"Ability of recombinant factor VIIa to reverses the anticoagulant effect of the pentasaccharide fondaparinux in healthy volunteers","volume":"106","author":"Bijsterveld","year":"2002","journal-title":"Circulation"},{"issue":"5","key":"10.1002\/14651858.CD005011.pub4-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1365-2141.2003.04811.x","article-title":"Recombinant factor VIIa reverses the anticoagulant effect of the long-acting pentasaccharide idraparinux in healthy volunteers","volume":"124","author":"Bijsterveld","year":"2004","journal-title":"British Journal of Haematology"},{"issue":"Suppl 5","key":"10.1002\/14651858.CD005011.pub4-BIB0044|cit44","first-page":"240s","article-title":"The treatment of bleeding is to stop the bleeding! Treatment of trauma-related hemorrhage","volume":"49","author":"Boffard","year":"2009","journal-title":"Transfusion"},{"issue":"5","key":"10.1002\/14651858.CD005011.pub4-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1365-2516.2007.01516.x","article-title":"A randomized, double-blind trial demonstrating bioequivalence of the current recombinant activated factor VII formulation and a new robust 25 degrees C stable formulation","volume":"13","author":"Bysted","year":"2007","journal-title":"Haemophilia"},{"key":"10.1002\/14651858.CD005011.pub4-BIB0046|cit46","first-page":"1","article-title":"Safety of activated recombinant factor VII in acute intracerebral hemorrhage: results of two multi-center placebo-controlled trials","volume":"34","author":"Davis","year":"2004","journal-title":"Internal Medicine Journal"},{"issue":"2-3","key":"10.1002\/14651858.CD005011.pub4-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1159\/000104481","article-title":"Impact of recombinant activated factor VII on health-related quality of life after intracerebral hemorrhage","volume":"23","author":"Diringer","year":"2007","journal-title":"Cerebrovascular Diseases"},{"issue":"Suppl 9","key":"10.1002\/14651858.CD005011.pub4-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1097\/BRS.0b013e3181d833f6","article-title":"Blood loss in major spine surgery: are there effective measures to decrease massive hemorrhage in major spine fusion surgery?","volume":"35","author":"Elgafy","year":"2010","journal-title":"Spine"},{"issue":"1","key":"10.1002\/14651858.CD005011.pub4-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1345\/aph.1P459","article-title":"Pharmacotherapy for mechanical circulatory support: a comprehensive review","volume":"45","author":"Ensor","year":"2011","journal-title":"Annals of Pharmacotherapy"},{"issue":"4","key":"10.1002\/14651858.CD005011.pub4-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/01.mbc.0000169218.15926.34","article-title":"A study of the pharmacokinetics and safety of recombinant activated factor VII in healthy Caucasian and Japanese subjects","volume":"16","author":"Fridberg","year":"2005","journal-title":"Blood Coagulation and Fibrinolysis"},{"issue":"4","key":"10.1002\/14651858.CD005011.pub4-BIB0051|cit51","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008085","article-title":"Pharmacological interventions to decrease blood loss and blood transfusion requirements for liver resection","author":"Gurusamy","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD005011.pub4-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1067\/mcp.2002.127740","article-title":"Pharmacodynamics of active site-inhibited factor VIIa in endotoxin-induced coagulation in humans","volume":"72","author":"Jilma","year":"2002","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD005011.pub4-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2147\/DDDT.S11764","article-title":"Evidence supporting the use of recombinant activated factor VII in congenital bleeding disorders","volume":"4","author":"Johansson","year":"2010","journal-title":"Drug Design, Development and Therapy"},{"issue":"3","key":"10.1002\/14651858.CD005011.pub4-BIB0054|cit54","first-page":"285","article-title":"The use of recombinant coagulation factor VIIa in patients undergoing surgical correction of scoliosis with the C-D method","volume":"7","author":"Kolban","year":"2005","journal-title":"Ortopedia Traumatologia Rehabilitacja"},{"issue":"1","key":"10.1002\/14651858.CD005011.pub4-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1365-2141.2010.08170.x","article-title":"Artificial contact pathway activation masks the haemostatic potential of rFVIIa and NN1731 in thrombocytopenic whole blood","volume":"150","author":"Larsen","year":"2010","journal-title":"British Journal of Haematology"},{"issue":"10","key":"10.1002\/14651858.CD005011.pub4-BIB0056|cit56","first-page":"980","article-title":"Active management of the third stage of labour: prevention and treatment of postpartum hemorrhage","volume":"31","author":"Leduc","year":"2009","journal-title":"Journal of Obstetrics and Gynaecology"},{"issue":"19","key":"10.1002\/14651858.CD005011.pub4-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1056\/NEJMoa1006221","article-title":"Safety of recombinant activated factor VII in randomized clinical trials","volume":"363","author":"Levi","year":"2010","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD005011.pub4-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.1503\/cmaj.100408","article-title":"Use of recombinant factor VIIa for the prevention and treatment of bleeding in patients without hemophilia: a systematic review and meta-analysis","volume":"183","author":"Lin","year":"2011","journal-title":"Canadian Medical Association Journal"},{"key":"10.1002\/14651858.CD005011.pub4-BIB0059|cit59","first-page":"153","article-title":"Recombinant factor VIIa: an assessment of evidence regarding its efficacy and safety in the off-label setting","volume":"2010","author":"Logan","year":"2010","journal-title":"Hematology\/the Education Program of the American Society of Hematology. American Society of Hematology. Education Program"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD005011.pub4-BIB0060|cit60","first-page":"94","article-title":"Use of small doses of recombinant factor VIIa during scoliosis surgery","volume":"86 B.C.","author":"Macieji","year":"2004","journal-title":"Journal of Bone and Joint Surgery (Proceedings)"},{"issue":"5","key":"10.1002\/14651858.CD005011.pub4-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.annemergmed.2009.01.027","article-title":"Evidence-based emergency medicine\/critically appraised topic. The efficacy of recombinant activated factor VII in severe trauma","volume":"54","author":"Nishijima","year":"2009","journal-title":"Annals of Emergency Medicine"},{"issue":"1","key":"10.1002\/14651858.CD005011.pub4-BIB0062|cit62","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007877.pub2","article-title":"Haemostatic drugs for traumatic brain injury","author":"Perel","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD005011.pub4-BIB0063|cit63","first-page":"E63","article-title":"rFVII for pediatric acute intracranial hemorrhage","volume":"38","author":"Perez","year":"2007","journal-title":"Stroke"},{"issue":"4","key":"10.1002\/14651858.CD005011.pub4-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ijoa.2007.06.001","article-title":"Recombinant factor VIIa should be used in massive obstetric haemorrhage","volume":"16","author":"Plaat","year":"2007","journal-title":"International Journal of Obstetric Anesthesia"},{"issue":"5","key":"10.1002\/14651858.CD005011.pub4-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/bja\/aem076","article-title":"Predicting response to recombinant factor VIIa in non-haemophilia patients with severe haemorrhage (1)","volume":"98","author":"Pugh","year":"2007","journal-title":"British Journal of Anaesthesia"},{"issue":"1","key":"10.1002\/14651858.CD005011.pub4-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1080\/22201173.2010.10872655","article-title":"The rational use of recombinant factor VIIa in the treatment of major intractable bleeding in the trauma patient","volume":"16","author":"Strydom","year":"2010","journal-title":"Southern African Journal of Anaesthesia and Analgesia"},{"issue":"2","key":"10.1002\/14651858.CD005011.pub4-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jhep.2011.01.043","article-title":"Recombinant activated factor VII in chronic liver diseases: should we be afraid of thromboembolic events?","volume":"55","author":"Thabut","year":"2011","journal-title":"Journal of Hepatology"},{"issue":"4","key":"10.1002\/14651858.CD005011.pub4-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ijoa.2007.06.002","article-title":"Recombinant factor VIIa should be used in massive obstetric haemorrhage","volume":"16","author":"Velde","year":"2007","journal-title":"International Journal of Obstetric Anesthesia"},{"issue":"6","key":"10.1002\/14651858.CD005011.pub4-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1097\/CCM.0b013e31819fff2c","article-title":"A multicenter, randomized, double-blind, placebo-controlled, dose-escalation trial assessing safety and efficacy of active site inactivated recombinant factor VIIa in subjects with acute lung injury or acute respiratory distress syndrome","volume":"37","author":"Vincent","year":"2009","journal-title":"Critical Care Medicine"},{"issue":"11","key":"10.1002\/14651858.CD005011.pub4-BIB0070|cit70","first-page":"812a","article-title":"Recombinant factor VIIa reverses the anticoagulant effect of the long-standing anticoagulant idraparinux in healthy volunteers","volume":"102","author":"Vink","year":"2004","journal-title":"Blood"},{"issue":"6","key":"10.1002\/14651858.CD005011.pub4-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1160\/TH03-09-0605","article-title":"Effect of recombinant factor VIIa on melagatran-induced inhibition of thrombin generation and platelet activation in healthy volunteers","volume":"91","author":"Woltz","year":"2004","journal-title":"Thrombosis and Haemostasis"},{"issue":"22","key":"10.1002\/14651858.CD005011.pub4-BIB0072|cit72","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V114.22.1403.1403","article-title":"Comparison of thromboembolic event rates in randomized controlled trials and observational studies of recombinant factor VIIa for off-label indications. A meta-analysis. ASH Annual Meeting Abstracts","volume":"114","author":"Yank","year":"2009","journal-title":"Blood"},{"issue":"8","key":"10.1002\/14651858.CD005011.pub4-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-154-8-201104190-00004","article-title":"Systematic review: benefits and harms of in-hospital use of recombinant factor VIIa for off-label indications","volume":"154","author":"Yank","year":"2011","journal-title":"Annals of Internal Medicine"},{"issue":"6","key":"10.1002\/14651858.CD005011.pub4-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.jocn.2009.11.020","article-title":"A meta-analysis of the efficacy and safety of recombinant activated factor VII for patients with acute intracerebral hemorrhage without hemophilia","volume":"17","author":"Yuan","year":"2010","journal-title":"Journal of Clinical Neuroscience"},{"key":"10.1002\/14651858.CD005011.pub4-BIB0075|cit75","unstructured":"Arai M Factor VIIa: Safety of Eptacog Alfa (activated) (genetical recombination) on adverse events and serious adverse events in patients with acute intracerebral haemorrhage ClinicalTrials.gov 2005"},{"key":"10.1002\/14651858.CD005011.pub4-BIB0076|cit76","unstructured":"Flaherty ML Jauch EC The spot sign for predicting and treating intracerebral hemorrhage growth study Clinicaltrials.gov 2008"},{"key":"10.1002\/14651858.CD005011.pub4-BIB0077|cit77","unstructured":"Gajewski JL Vogelsang G Key N Goodnough L A multi-center, randomized, double-blind, parallel groups, placebo-controlled trial on efficacy and safety of activated recombinant factor VII (rFVIIa\/NovoSeven) in the treatment of bleeding in patients following hematopoietic stem cell transplantation (HSCT) Novo Nordisk Clinical Trial ID: F7SCT-1485 2005"},{"key":"10.1002\/14651858.CD005011.pub4-BIB0078|cit78","unstructured":"Gladstone DJ Aviv RI Demchuk AM \"Spot sign\" selection of intracerebral hemorrhage to guide hemostatic therapy (SPOTLIGHT) ClinicalTrials.gov 2010"},{"key":"10.1002\/14651858.CD005011.pub4-BIB0079|cit79","unstructured":"Gris JC rhuFVIIa in post-partum hemorrhage ClinicalTrials.gov 2006"},{"key":"10.1002\/14651858.CD005011.pub4-BIB0080|cit80","unstructured":"Imberti R Efficacy and safety of factor VIIa (Eptacog Alfa) on rebleeding after surgery for spontaneous supratentorial intracerebral hemorrhage. A randomized, controlled, open-label, investigator-blinded pilot study ClinicalTrials.gov 2005"},{"key":"10.1002\/14651858.CD005011.pub4-BIB0081|cit81","doi-asserted-by":"crossref","unstructured":"Iorio A Randomized, open, prospective, multicenter pilot study to evaluate the efficacy and safety of activated recombinant factor VII in acute intracerebral haemorrhage in patients treated with oral anticoagulants or antiplatelets agents ClinicalTrials.gov 2006","DOI":"10.1111\/j.1538-7836.2007.tb01920.x"},{"key":"10.1002\/14651858.CD005011.pub4-BIB0082|cit82","unstructured":"Kelleher A A multi-centre, randomised, double-blind, placebo-controlled, dose-escalation trial of safety and efficacy of activated recombinant factor VII (Rfv11a\/NovoSeven) in the treatment of post-operative bleeding in patients following cardiac surgery requiring cardiopulmonary bypass http:\/\/www2.rbht.nhs.uk\/research\/projects"},{"key":"10.1002\/14651858.CD005011.pub4-BIB0083|cit83","unstructured":"McCall P Poustie S \"Salvage use\" of recombinant activated factor VII after inadequate haemostatic response to conventional therapy in complex cardiac surgery - a randomised placebo-controlled trial ClinicalTrials.gov 2005"},{"key":"10.1002\/14651858.CD005011.pub4-BIB0084|cit84","unstructured":"Molter NC Park MS Frail EA Effect of recombinant coagulation factor VIIa on peri-operative blood loss in patients undergoing major burn excision and grafting ClinicalTrials.gov 2005"},{"key":"10.1002\/14651858.CD005011.pub4-BIB0085|cit85","unstructured":"Ng C Use of recombinant activated factor seven (FVII) in bleeding ECMO patients post cardiac surgery. Randomised prospective study National Research Register 2005"},{"issue":"5","key":"10.1002\/14651858.CD005011.pub4-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/bja\/aei094","article-title":"Recombinant factor VIIa for life-threatening post-partum haemorrhage","volume":"94","author":"Ahonen","year":"2005","journal-title":"British Journal of Anaesthesia"},{"key":"10.1002\/14651858.CD005011.pub4-BIB0087|cit87","unstructured":"Della Corte F Efficacy and safety of factor VIIa on rebleeding after surgery for spontaneous intracerebral hemorhage (ICH) Clinical Trials.gov 2006"},{"issue":"1","key":"10.1002\/14651858.CD005011.pub4-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00001721-200301000-00021","article-title":"Recombinant factor VIIa in preterm neonates with prolonged prothrombin time","volume":"14","author":"Greisen","year":"2003","journal-title":"Blood Coagulation & Fibrinolysis"},{"issue":"1","key":"10.1002\/14651858.CD005011.pub4-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1046\/j.1537-2995.2002.00017.x","article-title":"Potential role for rVIIa in transfusion medicine","volume":"42","author":"Hedner","year":"2002","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD005011.pub4-BIB0090|cit90","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"1","key":"10.1002\/14651858.CD005011.pub4-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/SLA.0b013e318176c4ec","article-title":"Use of recombinant activated factor VII in patients without hemophilia: a meta-analysis of randomized control trials","volume":"248","author":"Hsia","year":"2008","journal-title":"Annals of Surgery"},{"issue":"3","key":"10.1002\/14651858.CD005011.pub4-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1445-5994.2007.01472.x","article-title":"Recombinant activated factor VII in critical bleeding: experience from the Australian and New Zealand Haemostasis Register","volume":"38","author":"Isbister","year":"2008","journal-title":"Internal Medicine Journal"},{"key":"10.1002\/14651858.CD005011.pub4-BIB0093|cit93","article-title":"Factor VIIa and tissue factor pathway inhibitor","volume-title":"Emerging Technologies in Transfusion Medicine","author":"Key","year":"2003"},{"issue":"12","key":"10.1002\/14651858.CD005011.pub4-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1111\/j.0041-1132.2003.00633.x","article-title":"Recombinant FVIIa for intractable hemorrhage: more questions than answers","volume":"43","author":"Key","year":"2003","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD005011.pub4-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"d7926","DOI":"10.1136\/bmj.d7926","article-title":"Evidence and desperation in off-label prescribing: recombinant factor VIIa","volume":"344","author":"Lipworth","year":"2012","journal-title":"BMJ"},{"issue":"8","key":"10.1002\/14651858.CD005011.pub4-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"516","DOI":"10.7326\/0003-4819-154-8-201104190-00002","article-title":"Off-label use of recombinant factor VIIa in U.S. hospitals: analysis of hospital records","volume":"154","author":"Logan","year":"2011","journal-title":"Annals of Internal Medicine"},{"issue":"6","key":"10.1002\/14651858.CD005011.pub4-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1046\/j.1365-2516.1998.00209.x","article-title":"A randomized, double-blind comparison of two dosage levels of recombinant factor VIIa in the treatment of joint, muscle and mucocutaneous haemorrhages in persons with haemophilia A and B, with and without inhibitors. rFVIIa Study Group","volume":"4","author":"Lusher","year":"1998","journal-title":"Haemophilia"},{"issue":"1","key":"10.1002\/14651858.CD005011.pub4-BIB0098|cit98","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004887.pub2","article-title":"Human recombinant activated factor VII for upper gastrointestinal bleeding in patients with liver diseases","author":"Mart\u00ed-Carvajal","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD005011.pub4-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1001\/jama.295.3.293","article-title":"Thromboembolic adverse events after use of recombinant human coagulation factor VIIa","volume":"295","author":"O'Connell","year":"2006","journal-title":"JAMA"},{"issue":"3","key":"10.1002\/14651858.CD005011.pub4-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1001\/archsurg.2007.66","article-title":"Efficacy and safety of recombinant activated factor VII in major surgical procedures","volume":"143","author":"Ranucci","year":"2008","journal-title":"Archives of Surgery"},{"key":"10.1002\/14651858.CD005011.pub4-BIB0101|cit101","unstructured":"The Nordic Cochrane Centre. The Cochrane Collaboration Review Manager (RevMan) 2008"},{"issue":"13","key":"10.1002\/14651858.CD005011.pub4-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1182\/blood-2004-06-2223","article-title":"The use of recombinant factor VIIa in the treatment of bleeding disorders","volume":"104","author":"Roberts","year":"2004","journal-title":"Blood"},{"issue":"3","key":"10.1002\/14651858.CD005011.pub4-BIB0103|cit103","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005951.pub2","article-title":"Haemostatic drug therapies for acute primary intracerebral haemorrhage","author":"You","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD005011.pub4-BIB0104|cit104","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005011.pub3","article-title":"Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia","author":"Lin","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD005011.pub4-BIB0105|cit105","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005011.pub2","article-title":"Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia","author":"Stanworth","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD005011.pub4\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T00:06:27Z","timestamp":1742774787000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD005011.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Injuries Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,3,14]]},"references-count":105,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2012,4]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd005011.pub4","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,14]]}}}